You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
泰凌醫藥(01011.HK):目前正在就潛在交易與獨立第三方進行磋商 明日復牌
格隆匯 04-20 19:28

格隆匯4月20日丨泰凌醫藥(01011.HK)公佈,公司董事會已注意到股價及成交量近期的不尋常變動。經作出一切有關公司於合理情況下的查詢後,董事會確認,公司目前正在就潛在收購若干單抗產品商業化權利("潛在收購")、潛在出售及搬遷集團若干的製造設施("潛在出售")及潛在戰略合作以開發集團的新產品("潛在合作",連同潛在收購及潛在出售,統稱"潛在交易")與獨立第三方進行磋商。

於公吿日期,有關磋商仍在進行當中。潛在交易未必會落實。有關潛在交易的條款及條件仍未落實,集團截至本公吿日期亦未就潛在交易訂立任何正式協議。概無保證潛在交易將會落實或最終完成。因此,潛在交易未必會進行。倘潛在交易落實,則其可能構成上市規則第十四章項下之須予公吿交易。公司將根據上市規則於適當時候作出進一步公吿。

除上交所述者外,董事會並不知悉有關股價及成交量變動的任何原因或任何須予以公佈,以避免公司證券出現虛假市場的資料,或根據證券及期貨條例須予以披露的任何內幕消息。

此外,公司已向聯交所申請自2022年4月21日(星期四)上午9時正起恢復股份買賣。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account